ID   MK13_HUMAN              Reviewed;         365 AA.
AC   O15264; O14739; O15124; Q6FI46; Q9UNU0;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   05-OCT-2010, entry version 115.
DE   RecName: Full=Mitogen-activated protein kinase 13;
DE            Short=MAP kinase 13;
DE            Short=MAPK 13;
DE            EC=2.7.11.24;
DE   AltName: Full=Mitogen-activated protein kinase p38 delta;
DE            Short=MAP kinase p38 delta;
DE   AltName: Full=Stress-activated protein kinase 4;
GN   Name=MAPK13; Synonyms=PRKM13, SAPK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ENZYME REGULATION.
RC   TISSUE=Pituitary;
RX   MEDLINE=97361837; PubMed=9218798; DOI=10.1093/emboj/16.12.3563;
RA   Goedert M., Cuenda A., Craxton M., Jakes R., Cohen P.;
RT   "Activation of the novel stress-activated protein kinase SAPK4 by
RT   cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison
RT   of its substrate specificity with that of other SAP kinases.";
RL   EMBO J. 16:3563-3571(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-180 AND TYR-182,
RP   MUTAGENESIS OF THR-180 AND TYR-182, ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Liver;
RX   MEDLINE=98043706; PubMed=9374491; DOI=10.1074/jbc.272.48.30122;
RA   Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., Di Padova F.,
RA   Ulevitch R.J., Han J.;
RT   "Characterization of the structure and function of the fourth member
RT   of p38 group mitogen-activated protein kinases, p38delta.";
RL   J. Biol. Chem. 272:30122-30128(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=97442431; PubMed=9295308; DOI=10.1074/jbc.272.38.23668;
RA   Wang X.S., Diener K., Manthey C.L., Wang S.-W., Rosenzweig B.,
RA   Bray J., Delaney J., Cole C., Zukowski M., Yao Z.;
RT   "Molecular cloning and characterization of a novel p38 mitogen-
RT   activated protein kinase.";
RL   J. Biol. Chem. 272:23668-23674(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=97350815; PubMed=9207191; DOI=10.1006/bbrc.1997.6849;
RA   Kumar S., McDonnell P.C., Gum R.J., Hand A.T., Lee J.C., Young P.R.;
RT   "Novel homologues of CSBP/p38 MAP kinase: activation, substrate
RT   specificity and sensitivity to inhibition by pyridinyl imidazoles.";
RL   Biochem. Biophys. Res. Commun. 235:533-538(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=99167471; PubMed=10066767; DOI=10.1074/jbc.274.11.7095;
RA   Hu M.C.-T., Wang Y.-P., Mikhail A., Qiu W.R., Tan T.-H.;
RT   "Murine p38-delta mitogen-activated protein kinase, a developmentally
RT   regulated protein kinase that is activated by stress and
RT   proinflammatory cytokines.";
RL   J. Biol. Chem. 274:7095-7102(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=20189614; PubMed=10727080;
RA   Herbison C.E., Sayer D.C., Bellgard M., Allcock R.J.N.,
RA   Christiansen F.T., Price P.;
RT   "Structure and polymorphism of two stress-activated protein kinase
RT   genes centromeric of the MHC: SAPK2a and SAPK4.";
RL   DNA Seq. 10:229-243(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   MEDLINE=99218452; PubMed=10201954;
RA   Hale K.K., Trollinger D., Rihanek M., Manthey C.L.;
RT   "Differential expression and activation of p38 mitogen-activated
RT   protein kinase alpha, beta, gamma, and delta in inflammatory cell
RT   lineages.";
RL   J. Immunol. 162:4246-4252(1999).
RN   [13]
RP   FUNCTION, AND ENZYME REGULATION.
RX   MEDLINE=21391699; PubMed=11500363; DOI=10.1093/emboj/20.16.4360;
RA   Knebel A., Morrice N., Cohen P.;
RT   "A novel method to identify protein kinase substrates: eEF2 kinase is
RT   phosphorylated and inhibited by SAPK4/p38delta.";
RL   EMBO J. 20:4360-4369(2001).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-41; VAL-282 AND THR-300.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Responds to activation by environmental stress and pro-
CC       inflammatory cytokines by phosphorylating downstream targets.
CC       Plays a role in the regulation of protein translation by
CC       phosphorylating and inactivating EEF2K.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation on threonine and
CC       tyrosine by either of two dual specificity kinases, MAP2K3 and
CC       MAP2K6.
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=1; IntAct=EBI-2116951, EBI-1170906;
CC       Q9ERV0:Pkd1 (xeno); NbExp=1; IntAct=EBI-2116951, EBI-2255297;
CC       Q15139:PRKD1; NbExp=2; IntAct=EBI-2116951, EBI-1181072;
CC   -!- TISSUE SPECIFICITY: Expressed in testes, pancreas, small
CC       intestine, lung and kidney. Abundant in macrophages, also present
CC       in neutrophils, CD4+ T-cells, and endothelial cells.
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-180 and Tyr-182, which activates
CC       the enzyme.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10488; CAA71512.1; -; mRNA.
DR   EMBL; U93232; AAB87639.1; -; mRNA.
DR   EMBL; AF015256; AAC51758.1; -; mRNA.
DR   EMBL; AF004709; AAC51374.1; -; mRNA.
DR   EMBL; AF092535; AAD23377.1; -; mRNA.
DR   EMBL; AF100546; AAF36772.1; -; mRNA.
DR   EMBL; BT007221; AAP35885.1; -; mRNA.
DR   EMBL; CR536490; CAG38729.1; -; mRNA.
DR   EMBL; Z95152; CAB08438.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03875.1; -; Genomic_DNA.
DR   EMBL; BC000433; AAH00433.1; -; mRNA.
DR   EMBL; BC001641; AAH01641.1; -; mRNA.
DR   EMBL; BC004428; AAH04428.1; -; mRNA.
DR   IPI; IPI00005741; -.
DR   PIR; JC5528; JC5528.
DR   RefSeq; NP_002745.1; -.
DR   UniGene; Hs.178695; -.
DR   PDB; 3COI; X-ray; 2.09 A; A=2-352.
DR   PDBsum; 3COI; -.
DR   ProteinModelPortal; O15264; -.
DR   IntAct; O15264; 94.
DR   MINT; MINT-1183220; -.
DR   STRING; O15264; -.
DR   PhosphoSite; O15264; -.
DR   PRIDE; O15264; -.
DR   Ensembl; ENST00000211287; ENSP00000211287; ENSG00000156711.
DR   GeneID; 5603; -.
DR   KEGG; hsa:5603; -.
DR   UCSC; uc003ols.1; human.
DR   CTD; 5603; -.
DR   GeneCards; GC06P036129; -.
DR   H-InvDB; HIX0022365; -.
DR   HGNC; HGNC:6875; MAPK13.
DR   HPA; CAB025854; -.
DR   HPA; HPA007667; -.
DR   MIM; 602899; gene.
DR   PharmGKB; PA30620; -.
DR   eggNOG; prNOG13426; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; O15264; -.
DR   OMA; EWKQHIY; -.
DR   OrthoDB; EOG94F8VP; -.
DR   PhylomeDB; O15264; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; p38gammadeltapathway; Signaling mediated by p38-gamma and p38-delta.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   NextBio; 21772; -.
DR   ArrayExpress; O15264; -.
DR   Bgee; O15264; -.
DR   CleanEx; HS_MAPK13; -.
DR   Genevestigator; O15264; -.
DR   GermOnline; ENSG00000156711; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008339; F:MP kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0006950; P:response to stress; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008352; MAPK_p38.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01773; P38MAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; FALSE_NEG.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell cycle; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    365       Mitogen-activated protein kinase 13.
FT                                /FTId=PRO_0000186286.
FT   DOMAIN       25    308       Protein kinase.
FT   NP_BIND      31     39       ATP (By similarity).
FT   MOTIF       180    182       TXY.
FT   ACT_SITE    150    150       Proton acceptor (By similarity).
FT   BINDING      54     54       ATP (By similarity).
FT   MOD_RES      47     47       Phosphoserine.
FT   MOD_RES     180    180       Phosphothreonine.
FT   MOD_RES     182    182       Phosphotyrosine.
FT   MOD_RES     350    350       Phosphoserine.
FT   VARIANT      41     41       S -> L (in dbSNP:rs55776345).
FT                                /FTId=VAR_042267.
FT   VARIANT     282    282       A -> V (in dbSNP:rs55990045).
FT                                /FTId=VAR_042268.
FT   VARIANT     300    300       A -> T (in dbSNP:rs41270090).
FT                                /FTId=VAR_042269.
FT   MUTAGEN     180    180       T->A: Loss of kinase activity.
FT   MUTAGEN     182    182       Y->A: Loss of kinase activity.
FT   CONFLICT     13     14       DV -> EL (in Ref. 4; AAC51374).
FT   CONFLICT     39     39       V -> W (in Ref. 4; AAC51374).
FT   CONFLICT     56     56       L -> P (in Ref. 3; AAC51758).
FT   CONFLICT    166    166       I -> V (in Ref. 3; AAC51758).
FT   CONFLICT    224    224       K -> R (in Ref. 3 and 5).
FT   HELIX         4      8
FT   STRAND        9     14
FT   STRAND       17     22
FT   STRAND       25     33
FT   STRAND       35     44
FT   TURN         45     47
FT   STRAND       50     58
FT   HELIX        63     78
FT   STRAND       88     91
FT   HELIX        97     99
FT   STRAND      104    108
FT   STRAND      111    113
FT   HELIX       114    116
FT   TURN        117    119
FT   HELIX       124    143
FT   HELIX       153    155
FT   STRAND      156    158
FT   STRAND      164    166
FT   HELIX       191    194
FT   HELIX       204    218
FT   STRAND      222    226
FT   HELIX       228    239
FT   HELIX       244    247
FT   HELIX       253    260
FT   TURN        270    273
FT   HELIX       279    288
FT   TURN        293    295
FT   HELIX       299    303
FT   HELIX       306    308
FT   TURN        309    311
FT   HELIX       314    316
FT   TURN        327    330
FT   HELIX       335    347
SQ   SEQUENCE   365 AA;  42090 MW;  52E749EDB2973DDF CRC64;
     MSLIRKKGFY KQDVNKTAWE LPKTYVSPTH VGSGAYGSVC SAIDKRSGEK VAIKKLSRPF
     QSEIFAKRAY RELLLLKHMQ HENVIGLLDV FTPASSLRNF YDFYLVMPFM QTDLQKIMGM
     EFSEEKIQYL VYQMLKGLKY IHSAGVVHRD LKPGNLAVNE DCELKILDFG LARHADAEMT
     GYVVTRWYRA PEVILSWMHY NQTVDIWSVG CIMAEMLTGK TLFKGKDYLD QLTQILKVTG
     VPGTEFVQKL NDKAAKSYIQ SLPQTPRKDF TQLFPRASPQ AADLLEKMLE LDVDKRLTAA
     QALTHPFFEP FRDPEEETEA QQPFDDSLEH EKLTVDEWKQ HIYKEIVNFS PIARKDSRRR
     SGMKL
//
